These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 20817787)

  • 1. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
    McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
    Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF activates and physically interacts with PAK to regulate cell motility.
    McCarty SK; Saji M; Zhang X; Knippler CM; Kirschner LS; Fernandez S; Ringel MD
    Endocr Relat Cancer; 2014; 21(6):865-77. PubMed ID: 25228413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration.
    Ma Y; McCarty SK; Kapuriya NP; Brendel VJ; Wang C; Zhang X; Jarjoura D; Saji M; Chen CS; Ringel MD
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1314-22. PubMed ID: 23709653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition.
    Knippler CM; Saji M; Rajan N; Porter K; La Perle KMD; Ringel MD
    Endocr Relat Cancer; 2019 Aug; 26(8):699-712. PubMed ID: 31146260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.
    Sun X; Su VL; Calderwood DA
    J Biol Chem; 2019 Sep; 294(39):14319-14332. PubMed ID: 31391252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.
    Ha BH; Morse EM; Turk BE; Boggon TJ
    J Biol Chem; 2015 May; 290(21):12975-83. PubMed ID: 25855792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic analysis of the expression and prognostic significance of PAKs in breast cancer.
    Dang Y; Guo Y; Ma X; Chao X; Wang F; Cai L; Yan Z; Xie L; Guo X
    Genomics; 2020 May; 112(3):2433-2444. PubMed ID: 31987914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
    Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN
    Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAK signaling in cancer.
    Ye DZ; Field J
    Cell Logist; 2012 Apr; 2(2):105-116. PubMed ID: 23162742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
    Parvathy M; Sreeja S; Kumar R; Pillai MR
    BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
    Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
    BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21-Activated Kinases in Thyroid Cancer.
    Bautista L; Knippler CM; Ringel MD
    Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32609833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.
    Goc A; Al-Azayzih A; Abdalla M; Al-Husein B; Kavuri S; Lee J; Moses K; Somanath PR
    J Biol Chem; 2013 Feb; 288(5):3025-35. PubMed ID: 23258534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer.
    Park J; Kim JM; Park JK; Huang S; Kwak SY; Ryu KA; Kong G; Park J; Koo BS
    Head Neck; 2015 Jul; 37(7):953-63. PubMed ID: 24634274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.
    Menges CW; Sementino E; Talarchek J; Xu J; Chernoff J; Peterson JR; Testa JR
    Mol Cancer Res; 2012 Sep; 10(9):1178-88. PubMed ID: 22798428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21-activated kinases: three more join the Pak.
    Jaffer ZM; Chernoff J
    Int J Biochem Cell Biol; 2002 Jul; 34(7):713-7. PubMed ID: 11950587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of PAK1 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells Through the ERK Pathway.
    Wang S; Wang SY; Du F; Han Q; Wang EH; Luo EJ; Liu Y
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):602-610. PubMed ID: 31394555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-7 regulates cell growth, migration and invasion via direct targeting of PAK1 in thyroid cancer.
    Yue K; Wang X; Wu Y; Zhou X; He Q; Duan Y
    Mol Med Rep; 2016 Sep; 14(3):2127-34. PubMed ID: 27430434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAK1 and PAK2 in cell metabolism regulation.
    Kořánová T; Dvořáček L; Grebeňová D; Röselová P; Obr A; Kuželová K
    J Cell Biochem; 2022 Feb; 123(2):375-389. PubMed ID: 34750857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P21 activated kinase signaling in cancer.
    Rane CK; Minden A
    Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.